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ablate renal nerve tissue is enhanced.
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BACKGROUND Catheter-based renal artery denervation therapy is
under evaluation as a therapeutic option in patients with resistant
hypertension. Despite promising data from initial studies, the lack of a
clear treatment effect from the SYMPLICITY HTN 3 trial raised con-
cerns around the efﬁcacy of renal denervation. Subsequent sub-
analysis has suggested signiﬁcant treatment effects if patients receive
more and circumferential lesions, suggesting that multi-electrode
renal denervation systems may reduce the risk of an inadequate renal
denervation procedure. In order to gain insights from a large patient
dataset, we investigated the safety and performance of the
EnligHTN Renal Denervation System (St. Jude Medical) in patients
with drug-resistant hypertension using poled data from all trials
performed to date. This is the ﬁrst report of pooled data from the
EnligHTN I, II and III trials.
METHODS The EnligHTN renal artery ablation catheter has 4 elec-
trodes attached on a basket mounted at the tip of the catheter. We
analysed data from the EnligHTN I, III and III trials which met the
following criteria: 18-80 years of age, an ofﬁce systolic BP 
160 mmHg, on three or more antihypertensive agents (including a
diuretic), and renal artery diameter  4mm and length  20mm. All
trials used the same renal artery ablation catheter, but in the
EnligHTN I and early phase of the EnligHTN II trials, sequential de-
livery of radiofrequency energy was performed, whereas with the
later phase of the EnligHTN II trial and the EnligHTN III trial the next
generation simultaneous delivery of radiofrequency was performed.
RESULTS To date 202 patients met this criteria from these 3 studies,
with 6 month follow up data available (EI n¼46, EII n¼119, EIII n¼37).
Mean age for the dataset was 62 yr.s with mean ofﬁce systolic BP at
baseline of 179mmHg and at 6 months of 158mmHg. Therefore a 6
month reduction in ofﬁce systolic BP of 21mmHg was noted (p<0.05).
Mean 24 hr systolic ABP at baseline was 156mmHg and at 6 months
was 148mmHg. This 8mmHg drop was statistically signiﬁcant
(p<0.0001). With regards BP reduction within this dataset, baseline
systolic ofﬁce and 24 hour ambulatory BP values at baseline were
predictors of the level of BP reduction. Enrollment within the ﬁrst in
human trials (EI&III) had larger observed reductions in BP. Complete
safety analysis including renal function and adverse events will be
included in the presentation.
CONCLUSIONS Pooled data from the complete EnligHTN clinical trial
dataset meeting traditional study deﬁnitions of resistant hyperten-
sion conﬁrm the efﬁcacy and safety of the EnligHTN multi-electrode
system for renal artery denervation. Future randomised controlled
trials in the patient population with next generation multi-electrode
renal denervation systems are warranted.
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BACKGROUND Clinical outcomes after surgical and endovascular
revascularization in elderly patients with critical limb ischemia (CLI)
remain undeﬁned. This study explored the rate and predictors of
mortality after revascularization in octogenarian patients with CLI.
METHODS From 2007 to 2011, 175 consecutive CLI patients (175 ﬁrst
treated limbs) over 80 years old (age, 854 years; 52% male; 57% non-
ambulatory status; 53% diabetics; 25% on hemodialysis and 77% with
tissue loss) who underwent revascularization for infrainguinal lesions
(endovascular therapy: 136, bypass surgery: 39) were retrospectively
enrolled. Overall survival rate after revascularization was evaluated
by Kaplan-Meier analysis. Predictors for 2-year mortality after revas-
cularization were determined using a Cox hazards model.
RESULTS Median follow-up duration was 17 [range 0-55] months.
Overall survival rate was 80% at 1 year, and 69% at 2 years, with
infection being the most common cause of death. Predictors of mor-
tality after revascularization were non-ambulatory status (hazard ra-
tio [95% conﬁdence interval], 3.02 [1.61-5.67]), body mass index <18.5
(1.86 [1.06-3.28]), and albumin <3 g/dL (2.48 [1.28-4.80]). Patients
with more predictors had a higher incidence of death after revascu-
larization. (Figure)CONCLUSIONS Non-ambulatory status, emaciation, and low albumin
level were independently associated with mortality after revascular-
ization in octogenarian patients with CLI. Risk stratiﬁcation by these
factors might inform revascularization strategy decision.
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